- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05214430
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
October 16, 2023 updated by: Zhu Weiming, Jinling Hospital, China
For patients with Crohn's diseases undergoing surgery,whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficacy of postoperative EEN for maintaining disease remission.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210000
- General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- CD patients who undergoing bowel resection with anastomosis
Exclusion Criteria:
- patients who received stoma creation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 3 months exclusive enteral nutrition after surgery
|
patients underwent intestinal resection and anastomosis in this arm will given over 3 months exclusive enteral nutrition,and free diet after 3 months.
|
Experimental: less than 1 months exclusive enteral nutrition after surgery
|
patients underwent intestinal resection and anastomosis in this arm will given over 3 months exclusive enteral nutrition,and free diet after 3 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative endoscopic recurrence
Time Frame: 1 YEAR
|
over i2b of rutgeerts score
|
1 YEAR
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
July 31, 2023
Study Registration Dates
First Submitted
January 26, 2022
First Submitted That Met QC Criteria
January 26, 2022
First Posted (Actual)
January 28, 2022
Study Record Updates
Last Update Posted (Actual)
October 17, 2023
Last Update Submitted That Met QC Criteria
October 16, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- jinlingH202001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Crohn Disease in Remission
-
NHS Greater Glasgow and ClydeUnknown
-
Radboud University Medical CenterErasmus Medical CenterActive, not recruitingCrohn Disease | Crohn Disease in RemissionNetherlands
-
University of MichiganRecruitingCrohn's Disease in RemissionUnited States
-
ViomeActive, not recruitingCrohn Disease | Ulcerative Colitis | Crohns Disease Aggravated | Crohn Disease in Remission | Irritable BowelUnited States
-
ProgenaBiomeRecruitingCrohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn's Gastritis | Crohn's Jejunitis | Crohn's Duodenitis | Crohn's Esophagitis | Crohn's | Crohn Disease of Ileum | Crohn Ileitis | Crohn's Disease Relapse | Crohns Disease Aggravated | Crohn Disease in Remission | Crohn's Disease of PylorusUnited States
-
Alimentiv Inc.Academic Medical Organization of Southwestern OntarioActive, not recruitingCrohn Disease | RemissionCanada, United Kingdom, Ukraine, Italy
-
Duzce UniversityRecruitingCrohn Disease | Nutrient; Excess | Remission/RegressionTurkey
-
University Medical Centre LjubljanaUnknownAdolescent | Child | Crohn Disease | Enteral Nutrition | Diet | RemissionSlovenia
-
University of California, Los AngelesCompletedMethamphetamine Dependence in Remission | Continuous Methamphetamine Dependence
-
Fujian Medical UniversityRecruiting
Clinical Trials on 3 months exclusive enteral nutrition after surgery
-
University of Alabama at BirminghamActive, not recruitingEnteral Feeding Intolerance | Premature; Infant, Light-for-datesUnited States
-
Children's Hospital of Fudan UniversityCompletedCrohn Disease | Enteral Nutrition | Gastrointestinal MicrobiomeChina
-
Prof. Arie LevineCompletedCrohn's DiseaseIsrael, Canada, Ireland, Spain
-
Jinling Hospital, ChinaCompleted
-
Prof. Arie LevineCompletedCrohn's DiseaseCanada, Israel
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompleted
-
Belal AlshaikhCompleted
-
Shanghai Zhongshan HospitalCompleted
-
Tel-Aviv Sourasky Medical CenterNot yet recruiting
-
NHS Greater Glasgow and ClydeUniversity of GlasgowUnknown